Recent Developments in Silicones for Topical and Transdermal Drug Delivery

References

• Park K Mrsny RJ . Controlled drug delivery: present and future. ACS Symp. Ser.752, 2–12 (2000).
   Google Scholar
• Suksaeree J Pichayakorn W Monton C Sakunpak A Chusut T Saingam W . Rubber polymers for transdermal drug delivery systems. Ind. Eng. Chem. Res.53, 507–513 (2014).
   Web of Science ®Google Scholar
• Gupta J Gill HS Andrews SN Prausnitz MR . Kinetics of skin resealing after insertion of microneedles in human subjects. J. Control. Release154, 148–155 (2011).
   PubMed Web of Science ®Google Scholar
• Prausnitz MR Langer R . Transdermal drug delivery. Nat. Biotechnol.26, 1261–1268 (2008).
   PubMed Web of Science ®Google Scholar
• Wagner H Kostka K-H Adelhardt W Schaefer UF . Effects of various vehicles on the penetration of flufenamic acid into human skin. Eur. J. Pharm. Biopharm.58, 121–129 (2004).
   PubMed Web of Science ®Google Scholar
• Kydonieus A Wille JJ . Transdermal delivery device development: a patent review. In : Skin Delivery Systems: Transdermals, Dermatologicals, and Cosmetic Actives. WilleJJ ( Ed.). Blackwell Publishing Professional, IA, USA, 259–275 (2006).
   Google Scholar
• Walters KA Brain KR . Topical and transdermal delivery. Drugs Pharm. Sci.199, 475–525 (2009).
   Google Scholar
• Fu XC Wang GP Liang WQ Chow MSS . Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration. J. Control. Release95, 209–216 (2004).
   PubMed Web of Science ®Google Scholar
• Liu T-Y Chen S-Y Li J-H Liu D-M . Study on drug release behaviour of CDHA/chitosan nanocomposites–effect of CDHA nanoparticles. J. Control. Release112, 88–95 (2006).
   PubMed Web of Science ®Google Scholar
• Sawant PD Luu D Ye R Buchta R . Drug release from hydroethanolic gels. Effect of drug's lipophilicity (log P), polymer-drug interactions and solvent lipophilicity. Int. J. Pharm.396, 45–52 (2010).
   PubMed Web of Science ®Google Scholar
• Miyajima M Koshika A Okada JI Ikeda M . Mechanism of drug release from poly(L-lactic acid) matrix containing acidic or neutral drugs. J. Control. Release60, 199–209 (1999).
   PubMed Web of Science ®Google Scholar
• Miyajima M Koshika A Okada JI Ikeda M Nishimura K . Effect of polymer crystallinity on papaverine release from poly (L-lactic acid) matrix. J. Control. Release49, 207–215 (1997).
   Web of Science ®Google Scholar
• Padula C Nicoli S Colombo P Santi P . Single-layer transdermal film containing lidocaine: modulation of drug release. Eur. J. Pharm. Biopharm.66, 422–428 (2007).
   PubMed Web of Science ®Google Scholar
• Tomlinson R Davey G : WO9823291A1 (1998).
   Google Scholar
• Valenta C Auner BG . The use of polymers for dermal and transdermal delivery. Eur. J. Pharm. Biopharm.58, 279–289 (2004).
   PubMed Web of Science ®Google Scholar
• Miller KJ . Transdermal product formulation development. In : Transdermal And Topical Drug Delivery: Principles And Practice. BensonHWatkinsonAC ( Eds). John Wiley & Sons, Inc., NJ, USA, 287–308 (2012).
   Google Scholar
• Owen MJ Dvornic PR . General introduction to silicone surfaces. Adv. Silicon Sci.4, 1–21 (2012).
   Google Scholar
• Noll W . Chemistry And Technology Of Silicones.Academic Press, Inc., NY, USA, 1–2 (1968).
   Google Scholar
• Smith AL . The Analytical Chemistry of Silicones. Wiley, NJ, USA (1991).
   Google Scholar
• Brook MA . Silicon in Organic Organometallic, and Polymer Chemistry. Wiley-VCH Verlag, NJ, USA (2000).
   Google Scholar
• Sene C . Silicone excipients for aesthetically superior and substantive topical pharmaceutical formulations. PharmaChem2, 17–20 (2003).
   Google Scholar
• Colas A Rafidison P . Silicones in new pharmaceutical developments, from formulations to manufacturing processes. PharmaChem4, 46–49 (2005).
   Google Scholar
• US National Library of Medicine DailyMed (2015). http://dailymed.nlm.nih.gov/dailymed/index.cfm.
   Google Scholar
• Subedi RK Oh SY Chun M-K Choi H-K . Recent advances in transdermal drug delivery. Arch. Pharm. Res.33 (3), 339–351 (2010).
   PubMed Web of Science ®Google Scholar
• Bhowmik D Chiranjib Chandira M Jayakar B Sampath KP . Recent advances in transdermal drug delivery system. Int. J. PharmTech Res.2 (1), 68–77 (2010).
   Google Scholar
• Paolino D Vono M Cilurzo F . Polymers-based devices for dermal and transdermal delivery. In : Polymeric Biomaterials. Taylor & Francis Group, FL, USA (2013).
   Google Scholar
• Mashak A Rahimi A . Silicone polymers in controlled drug delivery systems: a review. Iran. Polym. J.18 (4), 279–295 (2009).
   Web of Science ®Google Scholar
• US FDA . Skin protectant drug products for over-the-counter human use; reduced labeling; technical amendment. Fed. Regist.73, 6014–6017 (2008).
   Google Scholar
• Brand HM Brand-Garnys EE . Practical application of quantitative emolliency. Cosmetics Toiletries107, 93–99 (1992).
   Google Scholar
• Owen MJ . Why silicones behave funny. Chim. Nouv.22 (85), 27–33 (2004).
   Google Scholar
• Schalau G Ulman K . Silicone excipients in drug development. www.contractpharma.com/issues/2009-06/view_features/silicone-excipients-in-drug-development/.
   Google Scholar
• Aust DT Jones DP Shah BP : US20050287081A1 (2005).
   Google Scholar
• Draelos ZD . Sensitive skin: perceptions, evaluation, and treatment. Am. J. Contact Dermat.8 (2), 67–78 (1997).
   PubMedGoogle Scholar
• Nair B . Final report on the safety assessment of stearoxy dimethicone, dimethicone, methicone, amino bispropyl dimethicone, aminopropyl dimethicone, amodimethicone, amodimethicone hydroxystearate, behenoxy dimethicone, C24–28 alkyl methicone, C30–45 alkyl methicone, C30–45 alkyl dimethicone, cetearyl methicone, cetyl dimethicone, dimethoxysilyl ethylenediaminopropyl dimethicone, hexyl methicone, hydroxypropyldimethicone, stearamidopropyl dimethicone, stearyl dimethicone, stearyl methicone, and vinyldimethicone. Int. J. Toxicol.22 (Suppl. 2), 11–35 (2003).
   PubMedGoogle Scholar
• Van DKPC De HD De KJ Cobelens SA Kuipers MV . Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology200, 292–298 (2000).
   PubMed Web of Science ®Google Scholar
• Carroll CL Feldman SR Camacho FT Balkrishnan R . Better medication adherence results in greater improvement in severity of psoriasis. Br. J. Dermatol.151, 895–897 (2004).
   PubMed Web of Science ®Google Scholar
• Brown KK Rehmus WE Kimball AB . Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J. Am. Acad. Dermatol.55, 607–613 (2006).
   PubMed Web of Science ®Google Scholar
• Stedman T . Stedman's Medical Dictionary. Lippincott Williams and Wilkins, PA, USA (2005).
   Google Scholar
• Aguadisch LMJ : EP-966972-A1 (1999).
   Google Scholar
• Sene CN Neun D Tan-Sien-Hee L Ulman K . Silicones as excipients for topical formulations (2002). https://www.dowcorning.com/content/publishedlit/52-1034-01.pdf.
   Google Scholar
• De Paepe K Sieg A Le Meur M Rogiers V . Silicones as nonocclusive topical agents. Skin Pharmacol. Physiol.27, 164–171 (2014).
   PubMed Web of Science ®Google Scholar
• Lin SB Stark-Kasley LA : WO2009042535A2 (2009).
   Google Scholar
• Kennan JJ Messner KE : WO2009006091A2 (2009).
   Google Scholar
• Forbes CJ Lowry D Geer L et al. Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc. J. Control. Release156, 161–169 (2011).
   PubMed Web of Science ®Google Scholar
• Forbes CJ Mccoy CF Murphy DJ et al. Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides. J. Pharm. Sci.103, 1422–1432 (2014).
   PubMed Web of Science ®Google Scholar
• Aliyar H Huber R Loubert G Schalau G . Efficient ibuprofen delivery from anhydrous semisolid formulation based on a novel cross-linked silicone polymer Network: an in vitro and in vivo study. J. Pharm. Sci.103, 2005–2011 (2014).
   PubMed Web of Science ®Google Scholar
• Arvidsson P-O Farkas E Saeed CS et al. : WO2014090857A1 (2014).
   Google Scholar
• Harrison JJ Harrison N : US20140018328A1 (2014).
   Google Scholar
• Manfredini S Vertuani S : WO2011092581A2 (2011).
   Google Scholar
• Archer M Butterworth A : EP-2201926-A1 (2010).
   Google Scholar
• Klykken PC Nartker LS Raul VA Caprasse V : WO2006138035A1 (2006).
   Google Scholar
• Blizzard JD : WO2012158448A2 (2012).
   Google Scholar
• McGraw TL McGraw DM McGraw KC McGraw DV : US20100080768A1 (2010).
   Google Scholar
• Lee WA . WO2014011456A1 (2014).
   Google Scholar
• Bott RR Brandstadt KF Kollar C et al. : US20060083776A1 (2006).
   Google Scholar
• Bott RR Gebert MS Klykken PC Mazeaud I Thomas XJ-P : US20040105874A1 (2004).
   Google Scholar
• Huber RO Messner KE Nartker LS Raul VA Schalau GK : WO2012009048A1 (2012).
   Google Scholar
• Pedlar B . Covalon announces FDA clearance for SurgiClear™ antimicrobial silicone wound dressing (2012). www.covalon.com/press-release/30/covalon-announces-fda-clearance-for-surgiclear-antimicrobial-silicone-wound-dressing.
   Google Scholar
• Smith JM Thomas X Gantner DC Lin Z . Loosely cross-linked silicone elastomer blends and topical delivery. ACS Symp. Ser.846, 113–127 (2003).
   Google Scholar
• Anon . Soft silicone elastomer emulsion as topical drug delivery system. IP.com J.14, 1–8 (2014).
   Google Scholar
• Cauvin S Le Meur M Liles D Thomas X Vincent AM : WO2014019841A1 (2014).
   Google Scholar
• Plochocka K Chuang J-C Shih JS . Poly(N-vinyl-pyrrolidone)/silicone oil/water emulsion compositions for topical controlled-release drug delivery. Polym. Mater. Sci. Eng.84, 578–579 (2001).
   Google Scholar
• Hasenoehrl EJ Ponte JM Sabatelli AD : US6093408A (2000).
   Google Scholar
• Duffy JA Ptchelintsev DS . WO2001062247A1 (2001).
   Google Scholar
• Creevy KS . WO2010019155A1 (2010).
   Google Scholar
• Patel A . WO2009114419A1 (2009).
   Google Scholar
• Aliyar H Huber RO Liles DT Loubert GL Schalau GK Toth S : WO2013119633A1 (2013).
   Google Scholar
• Liles DT Mitchell TP : WO2013119561A1 (2013).
   Google Scholar
• Thomas X Mitchell TP : WO2012095752A2 (2012).
   Google Scholar
• Joffre EJ Mcauliffe JC Kollar C : WO2006071772A2 (2006).
   Google Scholar
• Kollar C Thomas X Caprasse V : WO2007139812A2 (2007).
   Google Scholar
• Colas A Horstman JB Swier S : WO2013148979A1 (2013).
   Google Scholar
• Kulesza JE : WO2014066225A1 (2014).
   Google Scholar
• Kulesza JE : US20110142769A1 (2011).
   Google Scholar
• Cohen DM Cooper ER : WO2010008600A1 (2010).
   Google Scholar
• Cohen DM Cooper ER : WO2010008601A1 (2010).
   Google Scholar
• Tamarkin D Eini M Friedman D et al. : US8486374B2 (2013).
   Google Scholar
• De Oliveira MaM Giorgi P Clark KL Reynolds JS : US20070071705A1 (2007).
   Google Scholar
• Vishnupad M : US20050255131A1 (2005).
   Google Scholar
• Vishnupad M : US20050255130A1 (2005).
   Google Scholar
• Pitre F Fredon L Mallard C : WO2005053666A1 (2005).
   Google Scholar
• US-FDA . National Drug Code Directory. www.fda.gov/Drugs/InformationOnDrugs/ucm142438.htm.
   Google Scholar
• Yeoh T . Current landscape and trends in transdermal drug delivery systems. Ther. Delive.3, 295–297 (2012).
   PubMedGoogle Scholar
• Lin SB Durfee LD Knott AA Schalau GK . Silicone pressure-sensitive adhesives. In : Technology of Pressure-Sensitive Adhesives and Products. BenedekIFeldsteinMM ( Eds). CRC Press, FL, USA (2009).
   Google Scholar
• Yeoh T . Profiles of recently approved transdermal drug delivery systems. Transdermal (2011).
   Google Scholar
• US-FDA . National Drug Code Directory NDC Search. www.accessdata.fda.gov/scripts/cder/ndc/default.cfm.
   Google Scholar
• Kokubo T Sugibayashi K Morimoto Y . Interaction between drugs and pressure-sensitive adhesives in transdermal therapeutic systems. Pharm. Res.11, 104–107 (1994).
   PubMed Web of Science ®Google Scholar
• Ahn TS Lee J-P Kim J Oh SY Chun M-K Choi H-K . Effect of pressure sensitive adhesive and vehicles on permeation of terbinafine across porcine hoof membrane. Arch. Pharmacol. Res.36 (11), 1403–1409 (2013).
   PubMed Web of Science ®Google Scholar
• Naruse M Ogawara K-I Kimura T Konishi R Higaki K . Development of transdermal therapeutic formulation of CNS5161, a novel N-methyl-D-aspartate receptor antagonist, by utilizing pressure-sensitive adhesives I. Biol. Pharm. Bull.35, 321–328 (2012).
   PubMed Web of Science ®Google Scholar
• Jackson K Miller KJ : US20050202073A1 (2005).
   Google Scholar
• Kanios D : WO2001052823A2 (2001).
   Google Scholar
• Kanios D : US20060078601A1 (2006).
   Google Scholar
• Lauterbach T Schollmayer E : WO2003092677A1 (2003).
   Google Scholar
• Mantelle J . WO2010006143A2 (2010).
   Google Scholar
• Stinchcomb AL Li G Banks SL Howard JL Golinski MJ : WO2011123866A1 (2011).
   Google Scholar
• Mori K Liu P : WO2014106009A1.
   Google Scholar
• Lee E-Y Chun M-K Chang J-S Choi H-K . Development of matrix based transdermal delivery system for ketotifen. J. Pharm. Invest.44, 291–296 (2014).
   Google Scholar
• Hille T Wauer G : WO2013088254A1 (2013).
   Google Scholar
• Algieri C Drioli E Donato L . Development of mixed matrix membranes for controlled release of ibuprofen. J. Appl. Polym. Sci.128, 754–760 (2013).
   Web of Science ®Google Scholar
• Panchaxari DM Pampana S Pal T Devabhaktuni B Aravapalli AK . Design and characterization of diclofenac diethylamine transdermal patch using silicone and acrylic adhesives combination. Daru21, 6 (2013).
   PubMed Web of Science ®Google Scholar
• Inoue K Ogawa K Okada JI Sugibayashi K . Enhancement of skin permeation of ketotifen by supersaturation generated by amorphous form of the drug. J. Control. Release108, 306–318 (2005).
   PubMed Web of Science ®Google Scholar
• Mantelle JA : US20110129535A1 (2011).
   Google Scholar
• Kanios D : US20060078602A1 (2006).
   Google Scholar
• Chun M-K Choi H-K . Transdermal delivery of estradiol and norethindrone acetate: effect of vehicles and pressure sensitive adhesive matrix. Yakche Hakhoechi35, 173–177 (2005).
   Google Scholar
• Raul VA Nartker LS Huber RO : WO2009009134A1 (2009).
   Google Scholar
• Choi YK : WO2004028515A1 (2004).
   Google Scholar
• Loubert GL Menjoulet TA Mitchell TP Thomas XJ-P : US20120114737A1 (2012).
   Google Scholar
• Liu Y Ouyang J Paul CW Foreman P Sridhar LM Shah S : WO2010124187A2 (2010).
   Google Scholar
• US-FDA . Residual drug in transdermal and related drug delivery systems. www.fda.gov/downloads/Drugs/Guidances/UCM220796.pdf.
   Google Scholar
• Ternes TA Joss A Siegrist H . Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environ. Sci. Technol.38, 392A–399A (2004).
   PubMed Web of Science ®Google Scholar
• Phillips PJ Smith SG Kolpin DW et al. Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environ. Sci. Technol.44, 4910–4916 (2010).
   PubMed Web of Science ®Google Scholar
• Ruiz AM Maerz JC Davis AK et al. Patterns of development and abnormalities among tadpoles in a constructed wetland receiving treated wastewater. Environ. Sci. Technol.44, 4862–4868 (2010).
   PubMed Web of Science ®Google Scholar
• Ternes TA Meisenheimer M Mcdowell D et al. Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol.36, 3855–3863 (2002).
   PubMed Web of Science ®Google Scholar
• Vieno NM Tuhkanen T Kronberg L . Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ. Sci. Technol.39, 8220–8226 (2005).
   PubMed Web of Science ®Google Scholar
• Santos P Watkinson AC Hadgraft J Lane ME . Formulation issues associated with transdermal fentanyl delivery. Int. J. Pharm.416, 155–159 (2011).
   PubMedGoogle Scholar
• Ratilal VP Vardhan GGH : IN2009MU01595A (2011).
   Google Scholar
• Hair PI Keating GM Mckeage K . Transdermal matrix fentanyl membrane patch (matrifen): in severe cancer-related chronic pain. Drugs68, 2001–2009 (2008).
   PubMed Web of Science ®Google Scholar
• Marier J-F Lor M Potvin D Dimarco M Morelli G Saedder EA . Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects. J. Clin. Pharmacol.46, 642–653 (2006).
   PubMed Web of Science ®Google Scholar
• Sharma S Good W : US20040202704A1 (2004).
   Google Scholar
• Miller KJ Govil SK Bhatia KS : US20040086551A1 (2004).
   Google Scholar
• Mueller W : WO2003018071A1 (2003).
   Google Scholar
• Brown TA Osborne J Rudella M Hunt B Malik V : WO2003015678A1 (2003).
   Google Scholar
• Stojanovic A Olveira S Fischer M Seeger S . Polysiloxane Nanotubes. Chem. Mater.25, 2787–2792 (2013).
   Web of Science ®Google Scholar
• Teixeira RFA Van Den Berg O Nguyen L-TT Feher K Du Prez FE . Microencapsulation of active ingredients using PDMS as shell material. Macromolecules47, 8231–8237 (2014).
   Web of Science ®Google Scholar
• Mokkaphan J Banlunara W Palaga T Sombuntham P Wanichwecharungruang S . Silicone surface with drug nanodepots for medical devices. ACS Appl. Mater. Interfaces6, 20188–20196 (2014).
   PubMed Web of Science ®Google Scholar